BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson's disease

被引：0
作者：
Poewe, W.
Kieburtz, K.
Stocchi, F.
Oren, S.
Yardeni, T.
Adar, L.
Rosenfeld, O.
Olanow, C.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
179
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of lornoxicam vs ibuprofen in primary dysmenorrhea: a randomized, double-blind, double dummy, active-controlled, cross over study
    Patel, Jayshree C.
    Patel, Parvati B.
    Acharya, Hemangini
    Nakum, Kanaklata
    Tripathi, C. B.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 188 : 118 - 123
  • [42] Raloxifene and Tibolone in Elderly Women: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial
    Jacobsen, Didy E.
    Melis, Rene J. F.
    Verhaar, Harald J. J.
    Rikkert, Marcel G. M. Olde
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2012, 13 (02) : 189.e1 - 189.e7
  • [43] A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum
    Villahermosa, LG
    Fajardo, TT
    Abalos, RM
    Balagon, MV
    Tan, EV
    Cellona, RV
    Palmer, JP
    Wittes, J
    Thomas, SD
    Kook, KA
    Walsh, GP
    Walsh, DS
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (05) : 518 - 526
  • [44] Erenumab versus topiramate for the prevention of migraine: Results of a randomized active-controlled double-dummy trial
    Reuter, U.
    Ehrlich, M.
    Gendolla, A.
    Heinze, A.
    Klatt, J.
    Wen, S.
    Hours-Zesiger, P.
    Nickisch, J.
    Sieder, C.
    Hentschke, C.
    Maier-Peuschel, M.
    HEADACHE, 2021, 61 : 174 - 175
  • [45] Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study
    Vecchi, M
    Meucci, G
    Gionchetti, P
    Beltrami, M
    Di Maurizio, P
    Beretta, L
    Ganio, E
    Usai, P
    Campieri, M
    Fornaciari, G
    De Franchis, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (02) : 251 - 256
  • [46] Design of a randomized, double-blind, double-dummy, placebo-controlled study of levodopa-carbidopa intestinal gel in patients currently receiving optimized treatment for advanced Parkinson's disease
    Olanow, C. W.
    Chatamra, K.
    Benesh, J.
    Pritchett, Y. L.
    Lenz, R. A.
    MOVEMENT DISORDERS, 2011, 26 : S137 - S137
  • [47] Cardiac safety profile of nebulized formoterol in adults with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial
    Nelson, Harold S.
    Gross, Nicholas J.
    Levine, Bernard
    Kerwin, Edward M.
    Rinehart, Mike
    Denis-Mize, Kimberly
    CLINICAL THERAPEUTICS, 2007, 29 (10) : 2167 - 2178
  • [48] Subgroup Analyses of a Phase 3 Randomized Study of Levodopa/Carbidopa Infusion (ND0612) for Parkinson's Patients
    Poewe, W.
    Espay, A.
    Lopes, N.
    Ferreira, J.
    MOVEMENT DISORDERS, 2024, 39 : S306 - S306
  • [49] Efficacy of opicapone in Parkinson's disease patients with motor fluctuations: A phase III, randomized, double-blind, placebo and active-controlled study - BIPARK I
    Ferreira, J.
    Lees, A.
    Santos, A.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S85 - S86
  • [50] VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis
    Schreiber, Stefan
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Danese, Silvio
    Colombel, Jean-Frederic
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Sands, Bruce E.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S612 - S613
12345